| S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
0.265 |
Evidence |
|
| STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
0.265 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
0.265 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
0.265 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
| S100A7 |
S100A7, PSOR1: Protein S100-A7 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
0.265 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
F11R |
F11R, JAM1, UNQ264/PRO301, JCAM: Junctional adhesion molecule A precursor |
0.265 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
0.265 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.265 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.265 |
Evidence |
|
| CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.265 |
Evidence |
|
| CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
ITGAE |
ITGAE: Integrin alpha-E precursor |
0.265 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SNCB |
SNCB: Beta-synuclein |
0.265 |
Evidence |
|